Is Wegovy Available on the NHS in 2025–2026?

You've been told to 'ask your GP', here's what happens next

Plenty of people arrive at their GP surgery having read about Wegovy and expecting a straightforward conversation. The reality is usually more complicated. A GP cannot, under current NHS commissioning, simply write a Wegovy prescription, the NICE recommendation for semaglutide (TA875) specifies that treatment must be delivered within a specialist weight management service with multidisciplinary support, including dietetic and psychological input where appropriate. Your GP's role, if they agree you meet the criteria, is to refer you, not to prescribe.

Once referred, you join a waiting list for that specialist service. Depending on your area, that wait can run to months, and if you are wondering when Wegovy is available on the NHS for people in your position, the honest answer is that timing varies significantly by region and service capacity. The NHS England weight management injections guidance makes clear that meeting the eligibility criteria does not guarantee immediate access; capacity constraints are real.

There's an important time limit too. NICE TA875 recommends semaglutide for a maximum of two years, and specifies stopping if less than five percent body weight is lost after six months on the maintenance dose. These conditions don't apply in the same way to private prescribing, where clinical decisions are made individually by a licensed prescriber.

Which BMI and conditions actually qualify for NHS Wegovy?

For England, the NICE criteria (TA875) require a BMI of 35 or above alongside at least one weight-related comorbidity, such as type 2 diabetes, hypertension, or obstructive sleep apnoea. People with a BMI between 30 and 34.9 may qualify if specialist referral criteria are met. Thresholds are typically 2.5 kg/m² lower for people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, reflecting different cardiometabolic risk profiles at lower BMI values.

You can read the full NICE recommendation (including the exact wording on eligibility and the specialist-service requirement) in NICE technology appraisal TA875. If your BMI sits below these thresholds, or if you have no qualifying comorbidity, NHS Wegovy is not currently available to you regardless of how long you wait, and our guide covering when Wegovy will be available on the NHS explains how the rollout picture may change over time.

Privately, the licensed eligibility is set by the medicine's authorisation: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition. A prescriber still assesses the full clinical picture (BMI alone doesn't determine suitability) but more people fall within the private-prescription criteria than the NHS threshold.

Scotland, Wales and Northern Ireland: the picture looks different

Devolved health systems each set their own access policies. Wegovy's availability through NHS Scotland follows separate Scottish Medicines Consortium guidance and clinical thresholds that differ from England's. Wales and Northern Ireland have their own commissioning frameworks. If you're outside England, the general rule of thumb (that NHS access exists but is restricted and patchy) holds, but the exact criteria will differ. NHS Inform Scotland provides useful nation-specific detail for Scottish patients.

The broader question of semaglutide's NHS availability sometimes causes confusion because Ozempic (also semaglutide) is prescribed on the NHS, but for type 2 diabetes management, not weight loss. Wegovy and Ozempic are the same molecule at different doses and with different licensed indications. Using Ozempic for weight loss is not how it is licensed, and it is not what NHS weight management pathways provide.

Private treatment: what the process actually looks like

For people who don't qualify for NHS Wegovy, or who do qualify but face a lengthy wait, private prescription through a regulated pharmacy is the established legal route. At nume, the process starts with a free online consultation reviewed the same day by a GPhC-registered Independent Prescriber. There's no algorithm making the decision, a named clinician reads your answers, checks your medical history and, if treatment is clinically appropriate, issues a prescription. Once approved and ordered before 12pm on a working day, your pen is dispatched the same day and arrives with DPD the next working day, in plain unbranded packaging. The pen lives in the fridge at home, and most people find slotting it into the same shelf as everyday cold items (salad dressings, leftovers) makes the weekly routine stick.

Everything is included in one transparent price: consultation, prescription, treatment and delivery. There are no subscription traps or auto-renewals; each repeat order is clinically reviewed before it goes out. You can explore the treatment options to see what's available, or verify our pharmacy on the GPhC register (registration number 9012878) at pharmacyregulation.org. For a wider look at how the private and NHS routes compare, the Wegovy overview page sets out both in more detail.